Multidisciplinary Delphi Consensus on management of children with moderate-severe atopic dermatitis - PubMed
5 hours ago
- #Delphi Consensus
- #Pediatrics
- #Atopic Dermatitis
- Multidisciplinary Delphi Consensus on managing moderate-severe atopic dermatitis (AD) in children.
- Type 2 inflammation is the most common endotype in pediatric AD.
- First-line treatments include corticosteroids (CS) and immunomodulatory agents to target type 2 inflammation.
- Biologics, especially dupilumab, have significantly altered AD treatment outcomes.
- A steering committee of pediatricians and dermatologists led a Delphi Consensus to standardize AD management.
- Experts agreed on statements regarding AD definition, diagnosis, and treatment.
- The consensus provides evidence-based recommendations for clinical practice.